CN103992381B - Polypeptide, peptide composition and polypeptide biomaterial and its preparation method and application - Google Patents
Polypeptide, peptide composition and polypeptide biomaterial and its preparation method and application Download PDFInfo
- Publication number
- CN103992381B CN103992381B CN201410153883.XA CN201410153883A CN103992381B CN 103992381 B CN103992381 B CN 103992381B CN 201410153883 A CN201410153883 A CN 201410153883A CN 103992381 B CN103992381 B CN 103992381B
- Authority
- CN
- China
- Prior art keywords
- polypeptide
- biomaterial
- peptide composition
- seq
- bleeding
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 108090000765 processed proteins & peptides Proteins 0.000 title claims abstract description 220
- 229920001184 polypeptide Polymers 0.000 title claims abstract description 177
- 102000004196 processed proteins & peptides Human genes 0.000 title claims abstract description 177
- 239000012620 biological material Substances 0.000 title claims abstract description 83
- 239000000203 mixture Substances 0.000 title claims abstract description 48
- 238000002360 preparation method Methods 0.000 title claims abstract description 16
- 239000002904 solvent Substances 0.000 claims abstract description 13
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 32
- 230000000025 haemostatic effect Effects 0.000 claims description 22
- 229940030225 antihemorrhagics Drugs 0.000 claims description 19
- 150000001413 amino acids Chemical class 0.000 claims description 5
- 239000003814 drug Substances 0.000 claims description 5
- 238000002156 mixing Methods 0.000 claims description 3
- 125000003275 alpha amino acid group Chemical group 0.000 abstract description 23
- 230000023597 hemostasis Effects 0.000 abstract description 20
- 238000000280 densification Methods 0.000 abstract description 5
- 239000002121 nanofiber Substances 0.000 abstract description 5
- 238000009776 industrial production Methods 0.000 abstract description 2
- 208000032843 Hemorrhage Diseases 0.000 description 58
- 208000034158 bleeding Diseases 0.000 description 56
- 231100000319 bleeding Toxicity 0.000 description 56
- 230000000740 bleeding effect Effects 0.000 description 56
- 239000008367 deionised water Substances 0.000 description 24
- 229910021641 deionized water Inorganic materials 0.000 description 24
- 239000000463 material Substances 0.000 description 23
- 210000004185 liver Anatomy 0.000 description 21
- 210000004369 blood Anatomy 0.000 description 14
- 239000008280 blood Substances 0.000 description 14
- 239000000243 solution Substances 0.000 description 11
- 230000002439 hemostatic effect Effects 0.000 description 10
- 241000700159 Rattus Species 0.000 description 8
- 230000001954 sterilising effect Effects 0.000 description 8
- 238000004659 sterilization and disinfection Methods 0.000 description 8
- 238000010171 animal model Methods 0.000 description 7
- 238000002474 experimental method Methods 0.000 description 7
- 238000000034 method Methods 0.000 description 7
- 108010073385 Fibrin Proteins 0.000 description 6
- 102000009123 Fibrin Human genes 0.000 description 6
- BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 description 6
- 241001465754 Metazoa Species 0.000 description 6
- 229950003499 fibrin Drugs 0.000 description 6
- 239000010445 mica Substances 0.000 description 6
- 229910052618 mica group Inorganic materials 0.000 description 6
- 238000003825 pressing Methods 0.000 description 6
- 229920001661 Chitosan Polymers 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 238000011160 research Methods 0.000 description 5
- 239000000523 sample Substances 0.000 description 5
- 238000002604 ultrasonography Methods 0.000 description 5
- 102000008186 Collagen Human genes 0.000 description 4
- 108010035532 Collagen Proteins 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- 239000003795 chemical substances by application Substances 0.000 description 4
- 229920001436 collagen Polymers 0.000 description 4
- 230000034994 death Effects 0.000 description 4
- 231100000517 death Toxicity 0.000 description 4
- 239000004033 plastic Substances 0.000 description 4
- 239000000843 powder Substances 0.000 description 4
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 4
- 230000008569 process Effects 0.000 description 4
- 238000012545 processing Methods 0.000 description 4
- 108010080379 Fibrin Tissue Adhesive Proteins 0.000 description 3
- 206010052428 Wound Diseases 0.000 description 3
- 208000027418 Wounds and injury Diseases 0.000 description 3
- 230000023555 blood coagulation Effects 0.000 description 3
- 210000001772 blood platelet Anatomy 0.000 description 3
- 229920002678 cellulose Polymers 0.000 description 3
- 239000001913 cellulose Substances 0.000 description 3
- 230000015271 coagulation Effects 0.000 description 3
- 238000005345 coagulation Methods 0.000 description 3
- 239000012769 display material Substances 0.000 description 3
- 239000007789 gas Substances 0.000 description 3
- 239000002874 hemostatic agent Substances 0.000 description 3
- 238000001727 in vivo Methods 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 230000010355 oscillation Effects 0.000 description 3
- 239000012071 phase Substances 0.000 description 3
- 238000010587 phase diagram Methods 0.000 description 3
- 239000004627 regenerated cellulose Substances 0.000 description 3
- 229910021642 ultra pure water Inorganic materials 0.000 description 3
- 239000012498 ultrapure water Substances 0.000 description 3
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- 206010002091 Anaesthesia Diseases 0.000 description 2
- 208000035473 Communicable disease Diseases 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 230000037005 anaesthesia Effects 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 239000010836 blood and blood product Substances 0.000 description 2
- 229940125691 blood product Drugs 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- RNFNDJAIBTYOQL-UHFFFAOYSA-N chloral hydrate Chemical compound OC(O)C(Cl)(Cl)Cl RNFNDJAIBTYOQL-UHFFFAOYSA-N 0.000 description 2
- 229960002327 chloral hydrate Drugs 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 239000004744 fabric Substances 0.000 description 2
- 239000000835 fiber Substances 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 210000003041 ligament Anatomy 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 239000012488 sample solution Substances 0.000 description 2
- 238000007789 sealing Methods 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 239000007790 solid phase Substances 0.000 description 2
- 239000007921 spray Substances 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- 238000001356 surgical procedure Methods 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 239000003643 water by type Substances 0.000 description 2
- 206010002198 Anaphylactic reaction Diseases 0.000 description 1
- 102000015081 Blood Coagulation Factors Human genes 0.000 description 1
- 108010039209 Blood Coagulation Factors Proteins 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- 241001269238 Data Species 0.000 description 1
- 101710145505 Fiber protein Proteins 0.000 description 1
- 102000008946 Fibrinogen Human genes 0.000 description 1
- 108010049003 Fibrinogen Proteins 0.000 description 1
- 206010018691 Granuloma Diseases 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 206010071229 Procedural haemorrhage Diseases 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 206010053476 Traumatic haemorrhage Diseases 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 208000030961 allergic reaction Diseases 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000036783 anaphylactic response Effects 0.000 description 1
- 208000003455 anaphylaxis Diseases 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 239000003114 blood coagulation factor Substances 0.000 description 1
- 210000004899 c-terminal region Anatomy 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 210000003979 eosinophil Anatomy 0.000 description 1
- 229940012952 fibrinogen Drugs 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 230000037361 pathway Effects 0.000 description 1
- 210000000578 peripheral nerve Anatomy 0.000 description 1
- 238000004393 prognosis Methods 0.000 description 1
- 125000006239 protecting group Chemical group 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 238000010189 synthetic method Methods 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
Landscapes
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Materials For Medical Uses (AREA)
Abstract
Description
Claims (8)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410153883.XA CN103992381B (en) | 2014-04-16 | 2014-04-16 | Polypeptide, peptide composition and polypeptide biomaterial and its preparation method and application |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410153883.XA CN103992381B (en) | 2014-04-16 | 2014-04-16 | Polypeptide, peptide composition and polypeptide biomaterial and its preparation method and application |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103992381A CN103992381A (en) | 2014-08-20 |
CN103992381B true CN103992381B (en) | 2018-04-24 |
Family
ID=51306745
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410153883.XA Active CN103992381B (en) | 2014-04-16 | 2014-04-16 | Polypeptide, peptide composition and polypeptide biomaterial and its preparation method and application |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103992381B (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107619431A (en) * | 2017-10-11 | 2018-01-23 | 青岛大学附属医院 | A kind of gel polypeptide that can be used for preparing hemostatic material |
CN107802883B (en) * | 2017-12-09 | 2020-08-14 | 青岛市妇女儿童医院 | Wound cleaning solution |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103665110A (en) * | 2013-12-06 | 2014-03-26 | 华南理工大学 | Half-path charge complementary type chiral self-assembled short-peptide nanometer biomedical material and application |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2802471A1 (en) * | 2010-06-14 | 2011-12-22 | Gene Signal International Sa | Novel peptides for wound healing |
US9149511B2 (en) * | 2011-06-30 | 2015-10-06 | Ethicon, Inc. | Procoagulant peptides and their derivatives and uses therefor |
-
2014
- 2014-04-16 CN CN201410153883.XA patent/CN103992381B/en active Active
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103665110A (en) * | 2013-12-06 | 2014-03-26 | 华南理工大学 | Half-path charge complementary type chiral self-assembled short-peptide nanometer biomedical material and application |
Also Published As
Publication number | Publication date |
---|---|
CN103992381A (en) | 2014-08-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Pan et al. | Mussel‐and barnacle cement proteins‐inspired dual‐bionic bioadhesive with repeatable wet‐tissue adhesion, multimodal self‐healing, and antibacterial capability for nonpressing hemostasis and promoted wound healing | |
JP6235104B2 (en) | Hemostatic composition | |
CN100384489C (en) | Hemostatic devices and methods of making same | |
CN101514225B (en) | Self-polymerization polypeptide and preparation method and application thereof | |
CN108348633A (en) | It is compacted stanch fibre cellulose aggregate | |
CN103816562B (en) | A kind of scars of war quick-acting haemostatic powder product and preparation method thereof | |
CN110559469B (en) | Medical adhesive | |
ES2673726T3 (en) | Biomaterials made from human hair | |
CN112107723B (en) | Medical water-based adhesive and using method thereof | |
BR112019003015B1 (en) | HEMOSTATIC COMPOSITIONS AND METHODS OF PREPARING THEM | |
CN109562199A (en) | Haemostatic powder with self-assembling peptides hydrogel | |
Zou et al. | Design of biopolymer-based hemostatic material: Starting from molecular structures and forms | |
Du et al. | Hemostasis strategies and recent advances in nanomaterials for hemostasis | |
Cheng et al. | Highly absorbent silk fibroin protein xerogel | |
CN113727740A (en) | Medical adhesive and preparation method and application thereof | |
CN103992381B (en) | Polypeptide, peptide composition and polypeptide biomaterial and its preparation method and application | |
CN106975098A (en) | A kind of complex polysaccharide hemostatic composition and preparation method and application | |
CN101450223A (en) | Hemostasia material based on chitosan, collagen and sodium cellulose glycolate and preparation method and use thereof | |
Yin et al. | Cellulose based composite sponges with oriented porous structure and superabsorptive capacity for quick hemostasis | |
KR20220035430A (en) | hemostatic powder | |
WO2004043503A1 (en) | Thrombin-carrying bioabsorbable synthetic nonwoven fabric | |
CN106110377B (en) | A kind of bioadhesive and its preparation method and application based on epsilon-polylysine | |
JP6877360B2 (en) | Hemostatic composition | |
Xu et al. | Biomimetic peptide nanoparticles participate in natural coagulation for hemostasis and wound healing | |
CN104744723B (en) | Chitosan medical material and its preparation method and application |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C41 | Transfer of patent application or patent right or utility model | ||
CB03 | Change of inventor or designer information |
Inventor after: Tang Chengkang Inventor after: Pu Shifeng Inventor before: Pu Shifeng |
|
COR | Change of bibliographic data | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20160128 Address after: Jinjiang District Dongguang street Chengdu city Sichuan province 610066 18 No. 3 Building 2 unit 6 Building No. 19 Applicant after: Tang Chengkang Address before: 610066 Sichuan city of Chengdu province Chenghua District Huaishu road Changrong Street 30 No. 4 Building 4 unit 1 floor No. 4 Applicant before: CHENGDU HANXINKANG BIOLOGICAL TECHNOLOGY CO.,LTD. |
|
C41 | Transfer of patent application or patent right or utility model | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20160317 Address after: 610041 Sichuan Province, Chengdu high tech Zone Yizhou Avenue North 388 No. 8 Building 17 layer 1710 Applicant after: CHENGDU VALENS MEDICAL TECHNOLOGY Co.,Ltd. Address before: Jinjiang District Dongguang street Chengdu city Sichuan province 610066 18 No. 3 Building 2 unit 6 Building No. 19 Applicant before: Tang Chengkang |
|
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right |
Effective date of registration: 20230630 Address after: No. 1026, 10th Floor, Building 2, No. 533 Jinyun Road, High tech Zone, Chengdu, Sichuan, 610000 Patentee after: Sichuan Xinyicheng Technology Co.,Ltd. Address before: No. 1710, 17th floor, building 8, No. 388, North Yizhou Avenue, Chengdu hi tech Zone, Sichuan 610041 Patentee before: CHENGDU VALENS MEDICAL TECHNOLOGY Co.,Ltd. |
|
TR01 | Transfer of patent right |